Revumenib Approved for KMT2A Translocation Leukemia ...Middle East

Medscape - News
The oral small molecule is the first drug approved for a major driver of acute leukemia in infants. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Revumenib Approved for KMT2A Translocation Leukemia )

Also on site :

Most viewed in News